Skip to content

Sleepwear fibre and sleep quality in menopausal women

An Investigation of the Impact of Sleepwear Fibre Type on Menopausal Sleep Quality

Status
Terminated
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12619000233123
Enrollment
16
Registered
2019-02-18
Start date
2020-01-21
Completion date
2023-02-27
Last updated
2025-09-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

This study compares the sleep outcomes (sleep quality) between two different sleepwear type (closely matched for fabric thickness and weight) in peri- and post-menopausal women. It is hypothesised that sleepwearA provides beneficial measured sleep outcomes (sleep quality and quantity, and sleep encephalograph power density) over sleepwearB.

Interventions

The study employs a within-subject, randomised, repeated-measures design with natural fibre for different sleepwear types, with close matching of fabric thickness and mass per unit area. Following baseline assessments and a familiarisation night, each participant will be randomised to four polysomnography test nights (2 nights in sleepwearA and 2 in sleepwearB) with at least 24 hours separating each study trial. Both sleepwear types are set in long sleeves and legs. The sleep laboratory will be

The study employs a within-subject, randomised, repeated-measures design with natural fibre for different sleepwear types, with close matching of fabric thickness and mass per unit area. Following baseline assessments and a familiarisation night, each participant will be randomised to four polysomnography test nights (2 nights in sleepwearA and 2 in sleepwearB) with at least 24 hours separating each study trial. Both sleepwear types are set in long sleeves and legs. The sleep laboratory will be maintained at 30C, 50% relative humidity.

Sponsors

The University of Sydney
Lead SponsorUniversity

Study design

Allocation
Randomised controlled trial
Intervention model
Crossover
Primary purpose
Treatment
Masking
Blinded (masking used) (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
All
Age
45 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

•peri-menopausal (experience cyclic irregularity over the preceding 12 months and up to 11 months of amenorrhea), or post-menopausal (have ceased menses for at least 1 year and not more than 2 years, or had bilateral oophorectomy at least six weeks before screening, and with Vasomotor scale of 2 or greater (Greene Climateric Scale) (Travers et al., 2005)

Exclusion criteria

•Currently use medication containing estrogen, progestins, or androgens within 8 weeks from the start of the study. •Have (or a history of) disorders that might affect sleep and/or thermoregulation (e.g., diabetes, cancer, heart disease, Raynaud's syndrome). •Have (or a history of) moderate to severe sleep breathing disorders, sleep disorders and psychiatric conditions (e.g., insomnia, restless leg syndrome, depression, schizophrenia). •Are on shift work or have crossed several time zones in the past fortnight. •Are unwilling to refrain from moderate-intense exercise of greater than 30 minutes or mild exercise of greater than 1h on each sleep study night.

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026